NO158004C - Fremgangsmaate for fremstilling av et preparat med cytolytisk aktivitet. - Google Patents

Fremgangsmaate for fremstilling av et preparat med cytolytisk aktivitet.

Info

Publication number
NO158004C
NO158004C NO821167A NO821167A NO158004C NO 158004 C NO158004 C NO 158004C NO 821167 A NO821167 A NO 821167A NO 821167 A NO821167 A NO 821167A NO 158004 C NO158004 C NO 158004C
Authority
NO
Norway
Prior art keywords
preparation
tumor
injection
immobilized
immune system
Prior art date
Application number
NO821167A
Other languages
English (en)
Other versions
NO821167L (no
NO158004B (no
Inventor
Johnathan L Kiel
Original Assignee
Johnathan L Kiel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnathan L Kiel filed Critical Johnathan L Kiel
Publication of NO821167L publication Critical patent/NO821167L/no
Publication of NO158004B publication Critical patent/NO158004B/no
Publication of NO158004C publication Critical patent/NO158004C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A61K38/385—Serum albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/18—Multi-enzyme systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
    • C12Y101/03—Oxidoreductases acting on the CH-OH group of donors (1.1) with a oxygen as acceptor (1.1.3)
    • C12Y101/03004—Glucose oxidase (1.1.3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01007—Peroxidase (1.11.1.7), i.e. horseradish-peroxidase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO821167A 1981-04-07 1982-04-06 Fremgangsmaate for fremstilling av et preparat med cytolytisk aktivitet. NO158004C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/251,694 US4486408A (en) 1981-04-07 1981-04-07 Insoluble crosslinked cytotoxic oxidase-peroxidase system

Publications (3)

Publication Number Publication Date
NO821167L NO821167L (no) 1982-10-08
NO158004B NO158004B (no) 1988-03-21
NO158004C true NO158004C (no) 1988-06-29

Family

ID=22953019

Family Applications (1)

Application Number Title Priority Date Filing Date
NO821167A NO158004C (no) 1981-04-07 1982-04-06 Fremgangsmaate for fremstilling av et preparat med cytolytisk aktivitet.

Country Status (13)

Country Link
US (1) US4486408A (no)
EP (1) EP0062434B1 (no)
JP (1) JPS57177694A (no)
AR (1) AR229260A1 (no)
AT (1) ATE15813T1 (no)
AU (1) AU556620B2 (no)
CA (1) CA1187791A (no)
DE (1) DE3266476D1 (no)
DK (1) DK155082A (no)
IL (1) IL65382A (no)
IN (1) IN156471B (no)
NO (1) NO158004C (no)
ZA (1) ZA821924B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4576817A (en) * 1984-06-07 1986-03-18 Laclede Professional Products, Inc. Enzymatic bandages and pads
EP0236610A1 (en) * 1986-03-13 1987-09-16 Laclede Professional Products, Inc. Enzymatic bandages and pads
SE8500341L (sv) * 1985-01-24 1986-07-25 Pharmacia Ab Desinfektionssats samt sett for desinfektion
US4974929A (en) * 1987-09-22 1990-12-04 Baxter International, Inc. Fiber optical probe connector for physiologic measurement devices
EP0361908A3 (en) * 1988-09-28 1990-09-05 Ideon Corporation Combination enzyme immunotherapeutics
FR2646777B1 (fr) * 1989-05-12 1993-09-03 Bio Serae Lab Procede de preparation d'un produit particulaire antimicrobien, produit antimicrobien obtenu et applications
US5486360A (en) * 1993-04-22 1996-01-23 St. Joseph Health Centre Method of treating tumour cells using catalase
EP0670040A1 (en) * 1993-09-22 1995-09-06 Baxter Diagnostics Inc. Immobilization of chemically cross-linked proteins on solid supports
US7192766B2 (en) * 2001-10-23 2007-03-20 Medtronic Minimed, Inc. Sensor containing molded solidified protein
CN103781905A (zh) 2011-07-06 2014-05-07 加利福尼亚大学董事会 多酶纳米复合物
WO2023200842A1 (en) * 2022-04-13 2023-10-19 Exoxemis, Inc. Compositions and methods for treating solid cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4004979A (en) * 1968-03-29 1977-01-25 Agence Nationale De Valorisation De La Recherche (Anvar) Preparation of active proteins cross-linked to inactive proteins
US4178362A (en) * 1969-06-03 1979-12-11 Telec S.A. Enzymatic dentifrices
US3638558A (en) * 1970-03-26 1972-02-01 Burger King Corp Cooking apparatus for comestibles immersed in heated oil
JPS528795B2 (no) * 1971-12-30 1977-03-11
DE2214442C3 (de) * 1972-03-24 1981-09-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Überführung von Glucose in Gluconsäure
DE2307904A1 (de) * 1973-02-17 1974-08-29 Hoechst Ag Verwendung von katalasefreien oder katalsearmen glucoseoxidase-praeparaten als zytostatikum fuer maligne zellen
DK146942C (da) * 1978-04-19 1984-07-30 Novo Industri As Fremgangsmaade til fremstilling af et immobiliseret enzymprodukt
DE2911192A1 (de) * 1979-03-22 1980-10-02 Boehringer Sohn Ingelheim Neuartiges immobilisiertes glucoseoxidase-katalasepraeparat und seine verwendung zur enzymatischen glucoseoxidation

Also Published As

Publication number Publication date
AU556620B2 (en) 1986-11-13
EP0062434A1 (en) 1982-10-13
CA1187791A (en) 1985-05-28
US4486408A (en) 1984-12-04
DK155082A (da) 1982-10-08
IL65382A0 (en) 1982-05-31
NO821167L (no) 1982-10-08
IL65382A (en) 1986-04-29
ZA821924B (en) 1983-04-27
AU8173982A (en) 1982-10-14
JPS57177694A (en) 1982-11-01
NO158004B (no) 1988-03-21
ATE15813T1 (de) 1985-10-15
DE3266476D1 (en) 1985-10-31
AR229260A1 (es) 1983-07-15
EP0062434B1 (en) 1985-09-25
IN156471B (no) 1985-08-10

Similar Documents

Publication Publication Date Title
NO168629C (no) Fremgangsmaate for fremstilling av oralt administrerbare, antidiabetisk virkende preparater
HU883981D0 (en) Process for the production of medical preparations with antiviral or antibacterial effect
NO158004C (no) Fremgangsmaate for fremstilling av et preparat med cytolytisk aktivitet.
AU582920B2 (en) Continuous release pharmaceutical compositions
AU576365B2 (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
FI875533A (fi) Insulinpreparat foer non-parenteral dosering.
UA34419C2 (uk) Ліофілізований препарат для ін'єкцій та спосіб інгібування росту пухлин
DK420385A (da) Antioestrogent laegemiddel til perkutan indgift
NO842290L (no) Fremgangsmaate for fremstilling av preparater inneholdende oralt antidiabetisk aktive stoffer
ES8606407A1 (es) Un procedimiento para preparar conjugados de galactosil-insulina
DE2964963D1 (en) Medical food based on liver powder and process for its preparation
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
US4330527A (en) Wound treatment agent
FI913511A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen aktivaattori-kohdistusosa -konjugaatin ja esilääkkeen valmistamiseksi
CA2098113A1 (en) Substances of polypeptide nature useful in human therapy
JPS57192316A (en) Manufacture of assimilative respiration promoting low molecular substance for prevention, remedy and cell tissue cultivation
IE52794B1 (en) Insoluble crosslinked cytotoxic oxidase-peroxidase system
IE780205L (en) Insulin-secretion promoting protein.
US4766150A (en) Method for immunosuppression
Farebrother et al. The histological effects of epithelial growth factor and its antiserum in the neonatal rat.
Bonta et al. Macrophages as targets of inhibitory effects of E-type prostaglandins in immune-related inflammation
EP0136093A3 (en) Anti-cancer factors
Panteleeva et al. On the thymoleptic activity of the Soviet antidepressants pyrazidol and incazan.
Vrubel et al. Influencing the survival of skin homografts by a lymphatic fistula
FR2392988A1 (fr) Nouveaux esters doues notamment d'activite pharmacologique, procedes de preparation de tels esters et compositions pharmaceutiques les renfermant